Reversal?Chart looks like the bottom is in and in the process of reversing...probably a multi year swing if this ends up cracking the last peak at $4.10
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0277 USD
−40.40 M USD
0.00 USD
1.43 B
About Immutep Ltd
Sector
Industry
CEO
Marc Voigt
Website
Headquarters
Sydney
Founded
1987
ISIN
AU000000IMM6
FIGI
BBG000PP3084
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Related stocks
IMMP - Swing IdeaAfter a reported 2M revenue compared to th3 145k expected, IMMP has been on a decent uptrend after finishing a double bottom.
If momentum continues, I can see a 3.09 IMMP easy
Blue box: Entry price
Red box: Stop loss
Green box: Take profit
immutep trendsKey trend lines on Immutep.
Immutep is close to breaking another key weekly trend line.
IMMUTEP Immutep hits a previous resistance and confirms it as a support,
we see oversold MACD and RSI which appear congruent with our idea of support.
IMMU can make its way to previous resistance now.
Trade Safe
Immutep ready for the next pushImmutep is nearly ready to push back up to previous highs or higher. wait for a cross above and fall back to confirm support on the ema on the daily. wait for macd crossover.
Sell at previous highs / resistances.
Taking This Chart out To Historic Levels With Pending CatalystIMMP has done great recovering from its last sell-off. But now it's back at a historic level of resistance that we clearly see on this chart right now. Upcoming potential catalyst this week will determine which direction it heads imo.
"Data from the TACTI-002 and INSIGHT-004 studies were publish
IMMP per request....I made another mess.Ok So I put lines everywhere from all over the place and in the confusion of it all some areas started to have some confluence.....everything kept pointing to $6.80. I appreciate the request to take a look at this.
by iCantw84it
05.27.2021
Please Like Subscribe if you would like to see more of th
Why $IMMP soared in December case studyFirst time an antigen presenting cell (APC) activator has shown an Overall Survival (OS) benefit in a randomised setting in metastatic breast cancer patients known to be insensitive to immune checkpoint inhibitor therapy
Promising and improving overall trend in OS in total population (based on appr
$IMMP: SmlCap play - Potential 20-80% upside from today's closesee boxes on chart for Entry, Exit and Stop loss zones. Never Chase.
Not for any recommendation, Just an Idea.
IMMP BullishThe MACD is curling up and it tested the .50 Fibonacci level. Also a few days ago it tested the 200 MA and bounced. This looks like a breakout over 1.82 with a first target of 2.12
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PRRUF is 0.1940 USD — it has decreased by −8.49% in the past 24 hours. Watch Immutep Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Immutep Ltd. stocks are traded under the ticker PRRUF.
We've gathered analysts' opinions on Immutep Ltd. future price: according to them, PRRUF price has a max estimate of 1.38 USD and a min estimate of 0.30 USD. Watch PRRUF chart and read a more detailed Immutep Ltd. stock forecast: see what analysts think of Immutep Ltd. and suggest that you do with its stocks.
PRRUF reached its all-time high on Dec 10, 2020 with the price of 0.8000 USD, and its all-time low was 0.0030 USD and was reached on Jul 31, 2008. View more price dynamics on PRRUF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PRRUF stock is 9.28% volatile and has beta coefficient of 1.55. Track Immutep Ltd. stock price on the chart and check out the list of the most volatile stocks — is Immutep Ltd. there?
Today Immutep Ltd. has the market capitalization of 223.22 M, it has increased by 0.13% over the last week.
Yes, you can track Immutep Ltd. financials in yearly and quarterly reports right on TradingView.
Immutep Ltd. is going to release the next earnings report on Feb 19, 2026. Keep track of upcoming events with our Earnings Calendar.
PRRUF earnings for the last half-year are −0.02 USD per share, whereas the estimation was −0.02 USD, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.02 USD per share. See more details about Immutep Ltd. earnings.
Immutep Ltd. revenue for the last half-year amounts to 591.82 K USD, despite the estimated figure of 0.00 USD. In the next half-year revenue is expected to reach 1.02 M USD.
PRRUF net income for the last half-year is −25.68 M USD, while the previous report showed −13.84 M USD of net income which accounts for −85.51% change. Track more Immutep Ltd. financial stats to get the full picture.
No, PRRUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRRUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Immutep Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Immutep Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Immutep Ltd. stock shows the sell signal. See more of Immutep Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.